Individual quality of life in long-term survivors of Hodgkin's lymphoma - A comparative study

Quality of Life Research

Volumn 12, Issue 5, 2003, Pages 545-554

  Wettergren, Lena ^a,b   Bjorkholm M ^b   Axdorph, U ^b   Bowling, A ^c   Langius Eklof A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Cancer survivors; General population; Health related quality of life; Hodgkin's lymphoma; Individual quality of life; SEIQoL DW

Indexed keywords

BLEOMYCIN; CARMUSTINE; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADAPTATION; ADULT; ARTICLE; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; FATIGUE; FEMALE; FINANCE; HEALTH STATUS; HODGKIN DISEASE; HUMAN; HUMAN RELATION; LEISURE; MAJOR CLINICAL STUDY; MALE; POPULATION; PRIORITY JOURNAL; QUALITY OF LIFE; SKIN MANIFESTATION; STRESS; SWEDEN; WORK CAPACITY;

ADULT; AGED; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; SURVIVORS;

EID: 0042856372     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025024008139     Document Type: Article

References (49)

1. Swerdlow AJ, Barber JA, Hudson GV, et al. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment. J Clin Oncol 2000; 18(3): 498-509.
2. van Leeuwen FE, Klokman WJ, Veer MB, et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 2000; 18(3): 487-497.
3. Massie MJ, Holland JC. Overview of normal reactions and prevalence of psychiatric disorders. In: Holland JC, Rowland JH (eds), Handbook of Psychooncology, Psychological Care of the Patient with Cancer. New York: Oxford University Press, 1989; 273-282.
4. Stark DP, House A. Anxiety in cancer patients. Br J Cancer 2000; 83(10): 1261-1267.
5. Kornblith A. Psychosocial adaptation of cancer survivors. In: Holland JC (ed.), Psychooncology. New York: Oxford University Press, 1998; 223-254.
6. Joly F, Henry-Amar M, Arveux P, et al. Late psychosocial sequelae in Hodgkin's disease survivors: A French population-based case-control study. J Clin Oncol 1996; 14(9): 2444-2453.
7. Loge JH, Abrahamsen AF, Ekeberg O, Kaasa S. Reduced health-related quality of life among Hodgkin's disease survivors: A comparative study with general population norms. Ann Oncol 1999; 10(1): 71-77.
8. van Tulder MW, Aaronson NK, Bruning PF. The quality of life of long-term survivors of Hodgkin's disease. Ann Oncol 1994; 5(2): 153-158.
9. Bloom JR, Fobair P, Gritz E, et al. Psychosocial outcomes of cancer: A comparative analysis of Hodgkin's disease and testicular cancer. J Clin Oncol 1993; 11(5): 979-988.
10. Abrahamsen AF, Loge JH, Hannisdal E, et al. Socio-medical situation for long-term survivors of Hodgkin's disease: A survey of 459 patients treated at one institution. Eur J Cancer 1998; 34(12): 1865-1870.
11. Fobair P, Hoppe RT, Bloom J, et al. Psychosocial problems among survivors of Hodgkin's disease. J Clin Oncol 1986; 4(5): 805-814.
12. Kornblith AB, Herndon JE II, Zuckerman E, et al. Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group B. Ann Oncol 1998; 9(3): 297-306.
13. Loge JH, Abrahamsen AF, Ekeberg O, Kaasa S. Hodgkin's disease survivors more fatigued than the general population. J Clin Oncol 1999; 17(1): 253-261.
14. Kornblith AB, Anderson J, Cella DF, et al. Hodgkin disease survivors at increased risk for problems in psychosocial adaptation. The Cancer and Leukemia Group B. Cancer 1992; 70(8): 2214-2224.
15. Loge JH, Abrahamsen AF, Ekeberg O, et al. Psychological distress after cancer cure: A survey of 459 Hodgkin's disease survivors. Br J Cancer 1997; 76(6): 791-796.
16. Greil R, Holzner B, Kemmler G, et al. Retrospective assessment of quality of life and treatment outcome in patients with Hodgkin's disease from 1969 to 1994. Eur J Cancer 1999; 35(5): 698-706.
17. Cella DF, Cherin EA. Quality of life during and after cancer treatment. Comprehensive Ther 1988; 14(5): 69-75.
18. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 1995; 273(1): 59-65.
19. Patrick DL, Chiang YP. Measurement of health outcomes in treatment effectiveness evaluations: Conceptual and methodological challenges. Med Care 2000; 38(9 Suppl.): 1144-1125.
20. Calman KC. Quality of life in cancer patients - an hypothesis. J Med Ethics 1984; 10(3): 124-127.
21. Bradley C. Importance of differentiating health status from quality of life. Lancet 2001; 357(9249): 7-8.
22. Hemminki E, Topo P, Kangas I. Experience and opinions of climacterium by Finnish women. Eur J Obstet Gynecol Reprod Biol 1995; 62(1): 81-87.
23. Browne JP, O'Boyle CA, McGee HM, et al. Development of a direct weighting procedure for quality of life domains. Qual Life Res 1997; 6: 301-309.
24. Hickey AM, Bury G, O'Boyle CA, et al. A new short form individual quality of life measure (SEIQoL-DW): Application in a cohort of individuals with HIV/AIDS. Br Med J 1996; 313: 29-33.
25. Bjorkholm M, Holm G, Mellstedt H, et al. Prognostic factors in Hodgkin's disease. I. Analysis of histopathology, stage distribution and results of therapy. Scand J Haematol 1977; 19(5): 487-495.
26. Grimfors G, Andersson B, Tullgren O, et al. Increased serum CD8 soluble antigen level is associated with blood lymphocyte abnormalities and other established indicators of a poor prognosis in adult Hodgkin's disease. Br J Haematol 1992; 80(2): 166-171.
27. Bjorkholm M, Axdorph U, Grimfors G, et al. Fixed versus response-adapted MOPP/ABVD chemotherapy in Hodgkin's disease. A prospective randomized trial. Ann Oncol 1995; 6(9): 895-899.
28. Askergren J, Bjorkholm M, Holm G, et al. Prognostic influence of early diagnostic splenectomy in Hodgkin's disease. A long-term follow-up. Acta Med Scand 1986; 219(3): 315-322.
29. Locker D, Grushka M. Response trends and nonresponse bias in a mail survey of oral and facial pain. J Public Health Dent 1988; 48(1): 20-25.
30. Polit DF, Hungler BP. Nursing Research: Principles and Methods. 6th ed. Philadelphia: Lippincott Williams & Wilkins, 1999.
31. O'Boyle CA. The schedule for the evaluation of the individual quality of life (SEIQoL). Int J Ment Health 1994; 23(3): 3-23.
32. O'Boyle CA, McGee H, Hickey A, et al. Individual quality of life in patients undergoing hip replacement. Lancet 1992; 339(May 2): 1088-1091.
33. Waldron D, O'Boyle CA, Kearney M, et al. Quality-of-life measurement in advanced cancer: Assessing the individual. J Clin Oncol 1999; 17(11): 3603-3611.
34. Bowling A. What things are important in people's lives? A survey of the public's judgements to inform scales of health related quality of life. Soc Sci Med 1995; 41(10): 1447-1462.
35. Lintern TC, Beaumont JG, Kenealy PM, Murrell RC. Quality of Life (QoL) in severely disabled multiple sclerosis patients: Comparison of three QoL measures using multidimensional scaling. Qual Life Res 2001; 10(4): 371-378.
36. Coen R, O'Mahony D, O'Boyle C, et al. Measuring the quality of life of dementia patients using the schedule for the evaluation of individual quality of life. Ir J Psychol 1993; 14(1): 154-163.
37. Bowling A. The effects of illness on quality of life: Findings from a survey of households in Great Britain. J Epidemiol Community Health 1996; 50: 149-155.
38. Neudert C, Wasner M, Borasio GD. Patients' assessment of quality of life instruments: A randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis. J Neurol Sci 2001; 191(1-2): 103-109.
39. Prince PN, Gerber GJ. Measuring subjective quality of life in people with serious mental illness using the SEIQoL-DW. Qual Life Res 2001; 10(2): 117-122.
40. Montazeri A, Milroy R, Gillis CR, McEwen J. Quality of life: Perception of lung cancer patients. Eur J Cancer 1996; 32A(13): 2284-2289.
41. Dow KH, Ferrell BR, Haberman MR, Eaton L. The meaning of quality of life in cancer survivorship. Oncol Nurs Forum 1999; 26(3): 519-528.
42. Cella DF, Tulsky DS. Measuring quality of life today: Methodological aspects. Oncology 1990; 4(5): 29-38.
43. Costantini M, Mencaglia E, Giulio PD, et al. Cancer patients as 'experts' in defining quality of life domains. A multicentre survey by the Italian Group for the Evaluation of Outcomes in Oncology (IGEO). Qual Life Res 2000; 9(2): 151-159.
44. Cella DF, Tross S. Psychological adjustment to survival from Hodgkin's Disease. J Consult Clin Psychol 1986; 54(5): 616-622.
45. Ferrell BR, Dow KH, Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res 1995; 4(6): 523-531.
46. Ferrell BR, Dow KH, Leigh S, et al. Quality of life in longterm cancer survivors. Oncol Nurs Forum 1995; 22(6): 915-922.
47. Official statistics in Sweden - Årsstatistik 99 för Stockholms län och landsting. Stockholm: Elanders Gotab, 1999; 132: 330-331.
48. Michelson H, Bolund C, Nilsson B, Brandberg Y. Health-related quality of life measured by the EORTC QLQ-C30 - reference values from a large sample of the Swedish population. Acta Oncol 2000; 39(4): 477-484.
49. Kreiger N, Nishri ED. The effect of nonresponse on estimation of relative risk in a case-control study. Ann Epidemiol 1997; 7(3): 194-199.